ChartRow logo
Data provided bySource: Twelve Data
CRL
$337.52+7.83%
as of close, Nov 6, 2026
☾ AH $337.52 +7.83%
PeersRVTYMEDPICLRIQVGHILMN
Share this page

CRL financial statements

The full income statement, balance sheet, and cash-flow statement for Charles River Laboratories (CRL), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +6.5%10Y CAGR +11.4%YoY −2.2%
$4B TTM$982.7M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Gross profit

5Y CAGR +12.5%5Y CAGR +12.5%YoY −3.5%
— FY25— Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating income

5Y CAGR −43.4%10Y CAGR −19.0%YoY +51.4%
$159M TTM$202.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Net income

5Y n/m10Y n/mYoY +512.0%
$40.2M TTM$333.1M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

EPS (diluted)

5Y n/m10Y n/mYoY +523.6%
$0.83 TTM$6.86 Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Operating cash flow

5Y CAGR +6.2%10Y CAGR +9.2%YoY +18.8%
$622.4M TTM$254.1M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Capital expenditure

5Y CAGR +5.6%10Y CAGR +13.2%YoY +31.6%
$222.8M TTM$46.8M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Free cash flow

5Y CAGR +6.4%10Y CAGR +7.8%YoY +16.3%
$399.6M TTM$207.3M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Shares (diluted)

5Y −2.1%10Y +4.1%YoY −1.7%
48.6M TTM48.6M Q3 '26
FY15FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25TTM
Q4 '16Q1 '17Q2 '17Q3 '17Q4 '17Q1 '18Q2 '18Q3 '18Q4 '18Q1 '19Q2 '19Q3 '19Q4 '19Q1 '20Q2 '20Q3 '20Q4 '20Q1 '21Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Every CRL chart on Trends →

Shares outstanding (point-in-time)

2024-09 51.1M2024-12 51.1M2025-03 49.1M2025-06 49.2M2025-09 49.2M2025-12 49.2M2026-03 48.2M2026-06 47.7M2026-09 47.9M-6.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 27 ’25as ofDec 28 ’24as ofDec 30 ’23as ofDec 31 ’22as ofDec 25 ’21
Revenue4.02B-0.9%4.05B-1.9%4.13B+3.9%3.98B+12.3%3.54B+21.1%
1.30B+17.5%1.10B+24.8%885M+9.1%812M+9.0%745M+16.2%
Selling, general & administrative743M-1.1%751M+0.4%748M+12.4%665M+7.3%620M+17.2%
Restructuring99.8M-6.7%107M+260.4%29.7M+261.4%8.21M+19.8%6.86M-45.6%
Amortization of intangibles179M+29.3%138M+0.8%137M-6.2%147M+17.4%125M+11.6%
Provision for credit losses6.06M-59.0%14.8M-18.9%18.2M+171.8%6.71M+304.7%1.66M-74.0%
Operating income25.2M-88.9%227M-63.2%617M-5.2%651M+10.4%590M+36.3%
Interest expense107M-15.3%126M-7.6%137M+130.6%59.3M-19.8%73.9M-14.5%
Interest & investment income4.94M-42.4%8.57M+65.0%5.20M+566.2%780K+19.6%652K-21.8%
Other non-operating income-22.6M-36.7%-16.5M-117.3%95.5M+213.0%30.5M+185.0%-35.9M-135.9%
Pre-tax income-99.5M-206.9%93.1M-84.0%581M-6.7%623M+29.6%481M+7.5%
Income tax42.7M-37.1%67.8M-32.8%101M-22.6%130M+59.2%81.9M+0.1%
-144M-750.1%22.2M-95.3%475M-2.4%486M+24.4%391M+7.3%
Net income to non-controlling interest2.17M-29.6%3.09M-46.3%5.75M-10.0%6.38M-18.8%7.86M+683.9%
Net income to common-144M-1501.7%10.3M-97.8%475M-2.4%486M+24.4%391M+7.3%
-$2.91-1555.0%$0.20-97.8%$9.22-2.7%$9.48+24.7%$7.60+5.6%
EPS (basic)-$2.91-1555.0%$0.20-97.8%$9.27-3.1%$9.57+23.2%$7.77+5.7%
Weighted-avg shares (basic)49.6M-3.5%51.4M+0.3%51.2M+0.8%50.8M+1.0%50.3M+1.5%
Weighted-avg shares (diluted)49.6M-4.0%51.6M+0.3%51.5M+0.3%51.3M-0.2%51.4M+1.6%
Balance Sheetas ofDec 27 ’25as ofDec 28 ’24as ofDec 30 ’23as ofDec 31 ’22as ofDec 25 ’21
1.45B+3.1%1.40B-12.8%1.61B+11.8%1.44B+12.9%1.27B+6.1%
Cash & equivalents214M+9.8%195M-29.7%277M+18.3%234M-3.0%241M+5.6%
Short-term investments
————1.06M+3.8%
Accounts receivable709M-1.7%721M-7.6%780M+3.7%752M+17.0%643M+4.1%
Inventory299M+7.4%279M-26.7%380M+48.6%256M+28.5%199M+7.2%
Prepaid expenses129M+22.1%106M+26.9%83.4M-22.5%108M+10.6%97.3M+34.1%
7.14B-5.2%7.53B-8.1%8.20B+7.8%7.60B+8.2%7.02B+27.9%
Property, plant & equipment1.66B+3.2%1.60B-2.2%1.64B+11.9%1.47B+13.5%1.29B+14.8%
Operating lease right-of-use361M-12.4%412M+4.7%394M+0.6%392M+33.7%293M+64.4%
Goodwill2.76B-2.9%2.85B-8.0%3.10B+8.6%2.85B+5.1%2.71B+49.9%
Intangible assets340M-53.0%723M-16.3%864M-9.5%955M-10.0%1.06B+34.7%
Deferred tax assets67.3M+59.6%42.2M+4.7%40.3M-2.4%41.3M+2.6%40.2M+6.6%
Other non-current assets293M+5.4%278M-10.1%309M+108.6%148M-2.1%152M-57.0%
1.12B+12.7%994M-5.8%1.06B-3.3%1.09B+5.7%1.03B+23.0%
Accounts payable149M+6.0%140M-16.9%169M-18.0%206M+3.9%198M+61.8%
Accrued liabilities270M+16.4%232M+1.8%228M+3.7%220M-4.0%229M+52.7%
Deferred revenue210M-15.3%248M+2.7%242M-8.5%264M+20.3%220M+5.7%
Short-term & current debt3.39M+15.9%2.93M-47.4%5.57M+51.5%3.68M+31.6%2.79M-94.4%
Current lease liability57.7M+6.5%54.2M-1.4%54.9M+18.0%46.5M+39.9%33.3M+34.8%
Other current liabilities222M+14.5%194M-4.5%203M-0.7%205M+45.7%140M+37.0%
Finance lease liability (current)3.23M+16.4%2.77M+15.7%2.40M+2.9%2.33M-13.5%2.69M-10.7%
3.92B-2.4%4.02B-11.4%4.54B-0.9%4.58B+3.3%4.43B+32.4%
Long-term debt2.14B-4.6%2.24B-15.4%2.65B-2.2%2.71B+1.7%2.66B+38.0%
Deferred revenue (non-current)45.6M+33.1%34.3M+10.9%30.9M—20.6M+5.7%
Non-current lease liability434M-10.3%484M+15.4%419M+7.6%390M+54.1%253M+62.6%
Operating lease liability (total)492M-8.6%538M+13.5%474M+8.7%436M+52.4%286M+58.8%
Finance lease liability (total)27.9M-2.0%28.4M-0.4%28.6M-6.8%30.6M+12.6%27.2M-6.3%
Finance lease liability24.6M-4.0%25.7M-1.8%26.2M-7.6%28.3M+15.4%24.5M-5.8%
Deferred tax liabilities95.2M-11.0%107M-44.1%191M-11.2%216M-10.1%240M+10.5%
Other non-current liabilities138M-29.2%195M-12.5%223M+27.7%175M-28.0%243M+18.3%
3.16B-8.6%3.46B-3.8%3.60B+20.9%2.98B+17.4%2.53B+19.9%
Preferred stock0.000.000.000.000.00
Common stock492K-3.7%511K-0.4%513K+0.8%509K+0.8%505K+1.4%
Additional paid-in capital1.95B-1.0%1.97B+3.2%1.91B+5.6%1.80B+5.0%1.72B+5.6%
Retained earnings1.39B-23.4%1.81B-4.0%1.89B+31.7%1.43B+46.1%981M+56.8%
Treasury stock0.000.000.000.000.00
Accumulated other comprehensive income-172M+45.9%-317M-61.6%-196M+25.0%-262M-59.1%-165M-18.6%
Non-controlling interest5.30M-2.7%5.45M+1.0%5.39M+12.7%4.79M+15.0%4.16M+16.7%
Total equity incl. non-controlling3.17B-8.6%3.47B-3.8%3.60B+20.8%2.98B+17.4%2.54B+19.9%
Total liabilities & equity7.14B-5.2%7.53B-8.1%8.20B+7.8%7.60B+8.2%7.02B+27.9%
Common shares issued49.2M-3.8%51.1M-0.4%51.3M+0.8%50.9M+0.9%50.5M+1.4%
Common shares outstanding49.2M-3.8%51.1M-0.4%51.3M+0.8%50.9M+0.9%50.5M+1.4%
Shares outstanding (cover)49.2M-3.7%51.1M-0.4%51.3M+0.7%51.0M+1.0%50.5M+1.4%
Cash Flowas ofDec 27 ’25as ofDec 28 ’24as ofDec 30 ’23as ofDec 31 ’22as ofDec 25 ’21
738M+0.4%735M+7.4%684M+10.4%620M-18.6%761M+39.2%
Depreciation & amortization403M+11.5%362M+15.2%314M+3.4%304M+14.4%266M+13.0%
Intangible amortization179M+29.3%138M+0.8%137M-6.2%147M+17.4%125M+11.6%
Share-based compensation71.1M+1.7%69.9M-3.0%72.0M-2.1%73.6M+3.0%71.5M+26.9%
Deferred income taxes-75.4M-12.2%-67.2M-30.9%-51.3M-55.1%-33.1M-63.0%-20.3M-1382.9%
Change in receivables-35.7M-65.4%-21.6M-164.6%33.4M-77.8%151M+465.4%26.6M-68.9%
Change in inventory48.8M+390.3%-16.8M-127.0%62.3M-20.7%78.5M+212.1%25.2M+36.9%
Change in payables2.87M+120.1%-14.3M+30.1%-20.4M-670.2%-2.65M-105.9%44.9M+5902.8%
-209M+14.6%-245M+56.5%-563M+7.4%-608M+57.7%-1.44B-139.0%
Capital expenditure219M-5.9%233M-26.9%319M-1.9%325M+41.9%229M+37.4%
Free cash flow518M+3.4%502M+37.3%365M+23.9%295M-44.6%532M+40.0%
Acquisitions0.00-100.0%5.48M-97.2%195M-31.3%283M-78.1%1.29B+208.9%
Purchases of investments20.1M-62.0%52.9M-2.5%54.2M-65.7%158M+247.4%45.6M+70.7%
Other investing activities-3.36M+26.0%-4.55M-298.3%2.29M-75.5%9.35M+3640.5%-264K-124.8%
-537M+2.6%-551M-544.2%-85.5M-101.7%-42.4M-106.3%673M+1323.5%
Long-term debt issued1.23B+13.5%1.08B+39.3%776M-73.7%2.95B-57.5%6.95B+211.6%
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.000.000.000.000.00
Common stock repurchased361M+202.6%119M+393.4%24.2M-37.5%38.7M-5.1%40.7M+69.8%
Dividends paid0.000.000.000.000.00
Other financing activities-14.0M+55.4%-31.4M-658.6%-4.14M+46.6%-7.76M0.00+100.0%
FX effect on cash18.8M+207.7%-17.5M-317.2%8.04M-68.6%25.6M+44.3%17.7M+2133.0%
Net change in cash10.4M+113.2%-78.9M-282.4%43.3M+948.4%-5.10M-138.7%13.2M+290.5%
Interest paid102M-17.6%123M-6.5%132M+31.1%101M+42.4%70.8M-2.3%
Income taxes paid120M-5.1%126M+39.5%90.4M+19.1%75.9M+0.6%75.4M+25.6%
Valuation Ratiosas ofDec 27 ’25as ofDec 28 ’24as ofDec 30 ’23as ofDec 31 ’22as ofDec 25 ’21
Market cap10.0B+5.3%9.52B-21.5%12.1B+9.4%11.1B-40.5%18.6B+48.8%
P/E—22.5×-12.0%25.5×+0.5%25.4×-45.9%47.0×+13.1%
P/S2.5×+6.3%2.3×-18.5%2.9×-1.9%2.9×-46.1%5.4×+22.7%
P/B2.9×+16.9%2.5×-31.4%3.7×-13.1%4.2×-45.0%7.7×+16.3%
P/FCF18.4×+8.5%17.0×-48.4%32.9×-17.0%39.6×-3.8%41.2×+46.9%
Earnings yield—4.5%+13.7%3.9%-0.5%3.9%+84.9%2.1%-11.6%
FCF yield5.4%-7.9%5.9%+93.8%3.0%+20.5%2.5%+4.0%2.4%-31.9%
Source filing10-K10-K10-K10-K10-K
Fiscal yearCEOTotal, as reportedActually paidOther executives, average$100 in the stock$100 in peers
FY2025Mr.Foster$15.4M$24.9M$3.6M$81.00$148.00
FY2024—$13.5M$3.1M$3.5M$74.00$129.00
FY2023—$14.1M$20.5M$3.7M$94.00$126.00
FY2022—$13.4M$10.7M$3.3M$87.00$124.00
FY2021—$13.7M$41.2M$4.4M$147.00$126.00
FY2020—$13.5M$50M$2.8M——

From the pay-versus-performance table of each proxy statement (DEF 14A), the newest that states the year. “Actually paid” values stock awards at the year’s closing price, so it falls when the stock does. A year two chief executives shared lists each one’s pay, as reported / actually paid, and the totals are both. $100 in the stock and in the peer group the proxy names are the newest proxy’s, from the start of its first year.

About this data

Source: CRL’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CRL filings on SEC EDGAR → Not investment advice.